Скачать или смотреть Why RepliCel may be the most compelling biotech company to watch in Canada

In this interview, Lee Buckler, President, and CEO of RepliCel Life Sciences, speaks with Natasha Frakes about the company’s successful repositioning. He discusses how RepliCel has changed their infrastructure, personnel, and resources in order to build the most value in their assets and programs. Most importantly, he mentions the success of the company’s clinical trials, and what this will mean for investors who have been waiting for this data. Lastly, Lee is preparing to position the company in the near term for another big transition, which will focus on generating revenue with their dermal injector, while continuing to develop exciting assets.

Learn more about RepliCel on their website: http://replicel.com/

If you want to learn more about the Market One Minute and how your company can reach millions of investors on BNN, please visit the Market One Minute section of our website here: http://bit.ly/2qGGbkd

Missed an episode of a Market One Minute segment? Here's a playlist to catch up on any you've missed: http://bit.ly/2s64IC0